Abstract:Ubiquitin C-terminal hydrolase-L1 (UCH-L1), an important member of de-ubiquitination enzyme families involved in the ubiquitin-proteasome pathway, is expressed mainly in neural and reproductive systems as well as in some tumours. Recently, expression of UCH-L1 has been discovered in parietal epithelial cells of Bowman's capsules and some tubular epithelia in the kidney. However, whether UCH-L1 is expressed in the capillary tufts of the glomeruli has not yet become clear. In this study, we used immunohistochemistry, double immunofluorescence labelling, immunoelectron microscopy in kidney biopsy tissues and western blot in cultured rat podocytes to investigate the expression of UCH-L1 and the regulation of this expression in podocytes. The results demonstrated that UCH-L1 was expressed in podocytes and its expression was significantly higher in acute proliferative glomerulonephritis (APGN), lupus nephritis (LN), membranous glomerulonephritis (MGN) and IgA nephropathy than that in focal segmental glomeruloselerosis (FSGS), minimal change disease (MCD), minor abnormality and normal kidney tissues (p < 0.05). In in vitro experiments, western blot showed that UCH-L1 expression significantly increased in the two groups of podocytes co-cultured with mesangial cells exposed to ATS 50 mu l/ml and ATS 50 mu l/ml with normal human serum 30 mu l/ml, respectively (p < 0.05), while the other groups treated with TGF beta 1 1 ng/ml, TNF alpha 10 ng/ml or IL-1 10 ng/ml had little rise of UCH-L1 expression, with no statistical significance compared with normal control (P > 0.05). Further tests indicated that the percentage of PCNA-positive podocytes in LN, APGN and IgA nephropathy was significantly higher than that in MCD, FSGS and normal control (p < 0.05). These data show for the first time that podocytes do express UCH-L1 and that its expression can be increased in these immunocomplex-mediated nephrites. The immune injury is a main cause for stimulating podocytes to express UCH-L1. The expression of UCH-L1 may be associated with the regeneration of podocytes as a repair response to immunocomplex-mediated injury. Copyright (C) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Neonatal Fc Receptor Stimulation Induces Ubiquitin C-Terminal Hydrolase-1 Overexpression in Podocytes Through Activation of P38 Mitogen-Activated Protein Kinase

NF‑κB upregulates ubiquitin C‑terminal hydrolase 1 in diseased podocytes in glomerulonephritis.

Expression of Neonatal Fc Receptor on Human Nephritis and Rat Nephritis Models

Mesangial Cell–Derived Exosomal Mir-4455 Induces Podocyte Injury in IgA Nephropathy by Targeting ULK2

UCH-L1 Expression of Podocytes in Diseased Glomeruli and in Vitro.

The Regulation of the UCH-L1 Gene by Transcription Factor NF-κB in Podocytes

Presence and possible impact of Fcγ receptors on resident kidney cells in health and disease

Podocyte-specific deletion of ubiquitin carboxyl-terminal hydrolase L1 causes podocyte injury by inducing endoplasmic reticulum stress.

A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury

Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy

Calcineurin Inhibitors Ameliorate PAN‐induced Podocyte Injury Through the NFAT–Angptl4 Pathway

[New Insight in Pathogenesis of Podocyte Disfunction in Minimal Change Disease].

The Activation of Extracellular Signal-Regulated Kinase is Responsible for Podocyte Injury

The immunosuppressive drug LF15-0195 acts also on glomerular lesions, by a change in cytoskeleton distribution in podocyte.

Over-expressing transient receptor potential cation channel 6 in podocytes induces cytoskeleton rearrangement through increases of intracellular Ca2+ and RhoA activation

A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies

Upregulated LRRC55 Promotes BK Channel Activation and Aggravates Cell Injury in Podocytes

Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage

R168H and V165X Mutant Podocin Might Induce Different Degrees of Podocyte Injury Via Different Molecular Mechanisms

Expression of Immunoglobulin G in Human Podocytes, and Its Role in Cell Viability and Adhesion

CD36 aggravates podocyte injury by activating NLRP3 inflammasome and inhibiting autophagy in lupus nephritis